Published in Curr Opin Nephrol Hypertens on March 01, 1994
The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int (1995) 3.70
Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int (1998) 3.09
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis (1996) 2.75
Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant (1996) 2.21
The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol (1995) 2.00
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int (1996) 1.99
Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol (1996) 1.64
Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64
Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol (2000) 1.52
Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int (1996) 1.46
The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am J Kidney Dis (1996) 1.30
Impact of renal transplantation on uremic cardiomyopathy. Transplantation (1995) 1.04
Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol (1998) 0.98
Cardiac disease in diabetic end-stage renal disease. Diabetologia (1997) 0.93
The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol (1991) 0.91
Cardiac and cerebrovascular disease in chronic uremia. Am J Kidney Dis (1993) 0.88
Development of a health questionnaire specific for end-stage renal disease. Nephron (1989) 0.88
Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine (Baltimore) (1991) 0.87
Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol (1996) 0.87
Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies. Transplantation (1987) 0.86
The clinical course of left ventricular hypertrophy in dialysis patients. Nephron (1990) 0.86
Recurrent hemoperitoneum in women receiving continuous ambulatory peritoneal dialysis. Ann Intern Med (1987) 0.81
The feasibility and efficacy of early discharge planning initiated by the admitting department in two acute care hospitals. Clin Invest Med (1994) 0.81
Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. Am J Nephrol (1990) 0.80
Symptoms in end-stage renal disease: dialysis v transplantation. Transplant Proc (1987) 0.79
Low-output left ventricular failure in end-stage renal disease. Am J Nephrol (1987) 0.78
Cardiac disease in chronic uremia. Pathophysiology and clinical epidemiology. ASAIO J (1994) 0.77
Erythromycin-cyclosporine interaction in renal transplant recipients. Transplantation (1987) 0.77
Congestive heart failure in dialysis patients. Arch Intern Med (1988) 0.76
Investigation and management of renal stones. Can Fam Physician (1989) 0.75
Clinical aspects of cardiomyopathy in dialysis patients. Blood Purif (1994) 0.75
Telemedicine and fetal ultrasonography in a remote Newfoundland community. CMAJ (2000) 0.75
The relationship between hypertension and left ventricular hypertrophy in renal transplant recipients. Transplant Proc (1988) 0.75
Hereditary renal diseases. Curr Opin Nephrol Hypertens (1993) 0.75
Heart failure and ischemic heart disease in chronic uremia. Curr Opin Nephrol Hypertens (1995) 0.75
Renal transplantation in primary hyperoxaluria/oxalosis: a report of two cases. Transplant Proc (1987) 0.75
Long-term cardiac morbidity and mortality during dialysis therapy. Adv Nephrol Necker Hosp (1994) 0.75
Clinical and echocardiographic heart disease in renal transplant patients: prevalence and risk factors. Transplant Proc (1987) 0.75